Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03482960 · ClinicalTrials.gov registry record · Early Phase 1
Comparison of 129Xe MRI With 19F MRI in CF Lung Disease
A Early Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT03482960 is a Early Phase 1 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 11 participants.
The verdict
NCT03482960, a Early Phase 1 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study is designed to compare the capabilities of two novel imaging techniques: polarized perfluorinated gas mixed with oxygen, and hyperpolarized xenon mixed with N2 to detect changes in lung ventilation using MRI.
Interventions
- DRUG PFP
- DRUG Hyperpolarized Xenon gas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-05-29 |
| Est. Completion | 2019-04-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03482960
The ClinicalTrials.gov registry entry for NCT03482960 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PFP is the first listed.
NCT03482960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03482960 about?
NCT03482960 is a clinical study titled "Comparison of 129Xe MRI With 19F MRI in CF Lung Disease". This study is designed to compare the capabilities of two novel imaging techniques: polarized perfluorinated gas mixed with oxygen, and hyperpolarized xenon mixed with N2 to detect changes in lung ventilation using MRI.
What is the current status of trial NCT03482960?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2018-05-29. Estimated completion is 2019-04-10.
What interventions are being tested in trial NCT03482960?
The interventions under investigation include: PFP (DRUG), Hyperpolarized Xenon gas (DRUG).
Who is sponsoring clinical trial NCT03482960?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.